k 2007

A new concept for modelling the number of cancer patients potentially treated in the Czech Republic

DUŠEK, Ladislav, Tomáš PAVLÍK, Eva GELNAROVÁ, Jan MUŽÍK, Jana KOPTÍKOVÁ et. al.

Základní údaje

Originální název

A new concept for modelling the number of cancer patients potentially treated in the Czech Republic

Název česky

Modelování počtu potenciálně léčených onkologických pacientů v ČR

Název anglicky

A new concept for modelling the number of cancer patients potentially treated in the Czech Republic

Autoři

Vydání

TIES 2007, 2007

Další údaje

Jazyk

čeština

Typ výsledku

Prezentace na konferencích

Obor

30200 3.2 Clinical medicine

Stát vydavatele

Česká republika

Utajení

není předmětem státního či obchodního tajemství

Organizační jednotka

Lékařská fakulta

ISBN

978-80-210-4333-6

Klíčová slova anglicky

modelling; cancer prevalence; cancer survival; cancer incidence

Štítky

Změněno: 30. 6. 2008 12:43, RNDr. Tomáš Pavlík, Ph.D.

Anotace

ORIG EN

V originále

The approach combines epidemiological trends in incidence and prevalence with demographic databases (used for estimates of relative X-yrs survival) and with cancer-specific mortality data that were applied to estimate the rate of dissemination relapses of the disease. The functionality and power of the model is well documented on Czech National Cancer Registry with more than 1,4 million of cases reported since 1977. Long-term history of the registry allows even 30-yrs relative survival estimates with mortality data separating death events due to cancer from the other reasons. Finally, summed numbers of patents that are probable to be treated in a given year are supported with reasonable confidence limits. All estimates are performed in age-specific format with respect to the clinical stage of the patients.

Anglicky

The approach combines epidemiological trends in incidence and prevalence with demographic databases (used for estimates of relative X-yrs survival) and with cancer-specific mortality data that were applied to estimate the rate of dissemination relapses of the disease. The functionality and power of the model is well documented on Czech National Cancer Registry with more than 1,4 million of cases reported since 1977. Long-term history of the registry allows even 30-yrs relative survival estimates with mortality data separating death events due to cancer from the other reasons. Finally, summed numbers of patents that are probable to be treated in a given year are supported with reasonable confidence limits. All estimates are performed in age-specific format with respect to the clinical stage of the patients.